VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $67,207,000 | +20.9% | 4,221,500 | +57.8% | 3.73% | -14.2% |
| Q4 2017 | $55,592,000 | +187.6% | 2,675,259 | +98.3% | 4.35% | +122.0% |
| Q3 2017 | $19,332,000 | -31.1% | 1,349,059 | -16.9% | 1.96% | -23.1% |
| Q2 2017 | $28,073,000 | +9.9% | 1,622,688 | -29.9% | 2.55% | +11.5% |
| Q1 2017 | $25,544,000 | +76.5% | 2,315,900 | +132.4% | 2.28% | +55.3% |
| Q4 2016 | $14,470,000 | +31.8% | 996,589 | +122.8% | 1.47% | +37.1% |
| Q3 2016 | $10,982,000 | +27.9% | 447,351 | +4.9% | 1.07% | +39.7% |
| Q2 2016 | $8,587,000 | +165.9% | 426,381 | +247.1% | 0.77% | +143.8% |
| Q1 2016 | $3,230,000 | – | 122,831 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |